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Nucleophosmin (NPM/B23) is a key regulator in the regulation of a number of processes including centro-
some duplication, maintenance of genomic integrity, and ribosome biogenesis. While the mechanisms under-
lying NPM function are largely uncharacterized, NPM loss results in severe dysregulation of developmental
and growth-related events. We show that NPM utilizes a conserved CRM1-dependent nuclear export sequence
in its amino terminus to enable its shuttling between the nucleolus/nucleus and cytoplasm. In search of NPM
trafficking targets, we biochemically purified NPM-bound protein complexes from HeLa cell lysates. Consistent
with NPM’s proposed role in ribosome biogenesis, we isolated ribosomal protein L5 (rpL5), a known chaperone
for the 5S rRNA. Direct interaction of NPM with rpL5 mediated the colocalization of NPM with maturing
nuclear 60S ribosomal subunits, as well as newly exported and assembled 80S ribosomes and polysomes.
Inhibition of NPM shuttling or loss of NPM blocked the nuclear export of rpL5 and 5S rRNA, resulting in cell
cycle arrest and demonstrating that NPM and its nuclear export provide a unique and necessary chaperoning
activity to rpL5/5S.
As the most prominent of subnuclear structures, the nucle-
olus has long been recognized as the site of active transcription
of rRNA and ribosome assembly (8). Various nucleolar pro-
teins, RNAs, and other factors have been implicated in the
complex process of ribosome production and maturation (18).
Recently, several groups reported the successful isolation and
mapping of the mammalian nucleolar proteome (1, 2, 44).
While these studies clearly identified proteins and ribonucleo-
proteins with purported roles in ribosome biogenesis, a sur-
prising number of proteins within the nucleolar proteome
(100) have no known function. In previous decades, it was
assumed that all nucleolar proteins must somehow contribute
to static ribosome biogenesis simply by virtue of their localiza-
tion. However, more-recent findings have demonstrated that
the nucleolus is a dynamic subnuclear organelle which regu-
lates numerous cellular processes, prompting a broadened
view of the potential functions of nucleolar proteins (28).
Nucleophosmin (NPM/B23) is an abundant phosphoprotein
that resides within the granular regions of the nucleolus (46).
Proliferating cells express NPM at high levels (9, 13), and NPM
has been associated with a variety of cellular events, including
ribosomal biogenesis, protein chaperoning, and centrosome
duplication (13, 23, 35, 36). Structurally, NPM is present in
both monomeric and multimeric states, although NPM mul-
timers appear predominant in the nucleolus and may be crucial
for the assembly of maturing ribosomes (33, 34, 53). Further-
more, NPM, along with other nucleolar proteins, is believed
(or has been shown) to actively mobilize into distinct subcel-
lular pools, supporting the notion that NPM trafficking may be
essential for its (proper) function (6). Indeed, NPM’s transit
from the nucleolus/nucleus is an essential event in S phase
progression; when NPM export was inhibited by the nucleolar
tumor suppressor ARF, cells arrested in G1 (7). Moreover, loss
of NPM expression results in severe attenuation of cellular
proliferation and increased apoptosis (5, 7, 16, 19), underscor-
ing NPM’s indispensable role within the cell.
Given that nuclear export of NPM promotes cell growth, we
aimed to further elucidate the crucial roles of NPM’s traffick-
ing. While numerous proteins, such as Mdm2, cdc14p, and
telomerase reverse transcriptase, are topologically restrained
in the nucleolus following receipt of defined cellular cues,
newly synthesized ribosomal subunits must be exported from
the nucleolus to promote proper protein translation in the
cytosol (45). Recent work with Xenopus laevis and Saccharo-
myces cerevisiae has shown that nuclear export of ribosomes
utilizes the CRM1-RanGTP export receptor pathway (20) as
well as the conserved nuclear adaptor protein NMD3 (51).
While investigating the critical nature of NPM trafficking, we
noted that NPM’s exit from the nucleus also involved the
classical CRM1-dependent nuclear export pathway. In search
of proteins that are targeted for NPM-mediated nuclear ex-
port, we observed that nuclear and cytosolic NPM proteins
directly bound to the ribosomal L5 protein (rpL5), a 60S sub-
unit protein that chaperones the 5S rRNA into the nucleolus
and out into the cytosol (31). Here we report that NPM me-
diates rpL5/5S nuclear export through a CRM1-dependent
mechanism, allowing NPM to directly access the maturing ri-
bosome and potentially regulate the protein translational ma-
chinery.
MATERIALS AND METHODS
Cell culture. HeLa and NIH 3T3 cells and wild-type (WT) mouse embryonic
fibroblasts (MEFs) (ArtisOptimus, Carlsbad, CA) were maintained in Dulbecco’s
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modified Eagle’s medium with 10% fetal bovine serum, 2 mM glutamine, 0.1 mM
nonessential amino acids, and 100 U penicillin and streptomycin.
Plasmid constructs. Vectors encoding full-length His-tagged murine NPM are
described elsewhere (7). The His epitope-tagged NPM coding sequence was
subcloned into pcDNA3.1 (Invitrogen) and pEGFP (Clontech) vectors. His-
NPM42–61, His-NPM62–83, or His-NPMdL mutants were generated using the
primers 5-GAAAATGAGCACCAGGCAGAAGCAATGAAC-3 (sense) and
5-GTTCATTGCTTCTGCCTGGTGCTCATTTTC-3 (antisense), 5-GTTAC
ACATCGTAGAGCAACCAACAGTTTCC-3 (sense) and 5-GGAAACTGTT
GGTTGCTCTACGATGTGTAAC-3 (antisense), or 5-GAAAATGAGCACC
AGGCGTCAGCAAGAACGGTC-3 (sense) and 5-CTAAACTGACCGTTCTT
GCTGACGCCTGGTGCTCATTTTC-3 (antisense), respectively, by QuikChange
mutagenesis (Stratagene). A myc-tagged NPC-M9 (40) in pcDNA3 and a green
fluorescent protein (GFP)-tagged rpL5 plasmid (41) were generous gifts from Alan
Diehl (University of Pennsylvania) and Joachim Hauber (Universitat Erlangen-
Nurnberg).
Heterokaryon assay. HeLa cells (2  105) were seeded onto glass coverslips
and transfected with plasmids. NIH 3T3 cells (6  105) were seeded onto the
HeLa cells 24 h posttransfection. Cocultures were then incubated for 30 min with
cycloheximide (100 g/ml), followed by incubation with 50% polyethylene glycol
in phosphate-buffered saline for 105 s. Cocultures were incubated with Dulbecco’s
modified Eagle’s medium containing cycloheximide (100 g/ml) for an additional
4 h. Heterokaryons were fixed and stained with a rabbit anti-His antibody (Santa
Cruz) or mouse anti-myc antibody (Zymed), followed by either fluorescein iso-
thiocyanate-conjugated or rhodamine X-conjugated anti-rabbit or anti-mouse
immunoglobulin (Pierce) as described previously (7). Nuclei were stained with
Hoechst (Sigma). Fluorescent signals were detected using a Nikon epifluorescence
compound microscope (100) fitted with a Nikon FDX-35 camera.
Immunoprecipitation and Western blot analysis. Cells were transduced as
recommended by the manufacturer (Amaxa) with vectors encoding His-NPM,
His-NPMdL, and GFP-rpL5 and lysed in binding buffer (25 mM Tris-HCl, pH 8,
150 mM NaCl, 1 mM EDTA, 0.1% NP-40) 48 h after the Nucleofector process.
Primary antibody to the NPM N terminus (custom rabbit; Sigma Genosys), GFP
(Santa Cruz), His (Santa Cruz), rpL5 (12), or nonimmune rabbit serum (NRS)
was added to the binding reaction mixtures. Immune complexes were precipi-
tated with protein A-Sepharose (Amersham). The precipitated proteins were
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to polyvinylidene difluoride (PVDF) membranes. NPM,
His-tagged proteins, and GFP-tagged proteins were visualized by direct immu-
noblotting with NPM (Zymed), His (Santa Cruz), and rpL5 and GFP (Santa
Cruz) antibodies, respectively.
Fluid phase liquid chromatography. For affinity chromatography, a rabbit
polyclonal antibody recognizing the N terminus of NPM (Sigma) was coupled to
N-hydroxysuccinimide-activated Sepharose (Amersham). HeLa cells were lysed
in 20 mM Tris, pH 7.4, and 0.1% Tween 20 and sonicated. Lysates (600 g) were
injected onto the NPM affinity column, washed with 20 mM Tris, and eluted with
an increasing NaCl gradient (0.1 to 1 M) using BioLogic fluid phase liquid affinity
chromatography and HR software (Bio-Rad). Fractions were precipitated with
trichloroacetic acid (TCA). Proteins were resuspended in 1 M Tris-HCl (pH 7.4),
separated by SDS-PAGE, and visualized with Coomassie blue stain (Sigma).
Proteomic analysis. Proteins from fluid phase liquid affinity chromatography
fractions were precipitated with TCA and resuspended in Laemmli buffer. SDS-
PAGE-separated proteins were stained with SYPRO-Ruby (Bio-Rad). Bands of
interest were excised and processed for trypsin digestion. Tryptic peptides were
calibrated with Sequazyme peptide mass standard kit (PE Biosystem) and ana-
lyzed by matrix-assisted laser desorption ionization–time of flight (MALDI-
TOF) mass spectrometry (Voyager DE Pro; Applied Biosystems). Identification
of proteins was performed using MS-Fit software (http://prospector.ucsf.edu
/ucsfhtml4.0/msfit.htm). MALDI-TOF spectra and sequences were verified using
a 4700 Proteomics tandem mass spectrometry system (Applied Biosystems).
Identified proteins were additionally verified by direct Western blot analysis.
Bacterial protein purification. BL21 cells were transformed with pET28a
vectors encoding NPM, NPMdL, rpL5, and p27kip1 proteins. Protein production
was induced for 3 h with 1 mM IPTG (isopropyl--D-thiogalactopyranoside).
Harvested cells were lysed in phosphate-buffered saline containing protease
inhibitors and 1% Triton X-100 with sonication. Cleared lysates were subjected
to affinity purification using Ni-nitrilotriacetic acid columns as described by the
manufacturer (Sigma). Purified proteins were separated by SDS-PAGE and
visualized for purity using Coomassie blue stain.
Subcellular fractionation. HeLa cells were subjected to the Nucleofector pro-
cess with scrambled or small interfering NPM RNAs or control vector, His-NPM,
and His-NPMdL and harvested. Pellets containing equal cell numbers were
resuspended in HEPES buffer (10 mM HEPES, pH 7.4, with 4 mM MgCl2, 1 mM
phenylmethylsulfonyl fluoride [PMSF], 10 g/ml leupeptin, 10 g/ml aprotinin, 1
g/ml pepstatin) and lysed with a syringe. Lysates were pelleted, and the super-
natant was saved as the cytoplasmic fraction. The pellet was resuspended in
fractionation buffer (10 mM Tris, pH 7.5, 10 mM NaCl, 1 mM EDTA, 0.5 mM
EGTA, 4 mM MgCl2, 1 mM PMSF, 10 g/ml leupeptin, 10 g/ml aprotinin, 1
g/ml pepstatin), subjected to Dounce homogenization, layered over a cushion
of sucrose (45%, wt/vol, in fractionation buffer), and centrifuged. The pellet was
washed and resuspended in EBC buffer (50 mM Tris-HCl, pH 7.4, 120 mM NaCl,
1 mM EDTA, 0.5% NP-40, 1 mM PMSF, 10 g/ml leupeptin, 10 g/ml aprotinin,
1 g/ml pepstatin, 1 mM NaF, 10 mM NaVO4, -glycerophosphate). Nuclear or
cytoplasmic protein was subjected to SDS-PAGE. Superoxide dismutase (SOD;
Cu/Zn-specific form), lamin A/C, and rpL5 proteins were visualized by direct
immunoblotting with anti-SOD (Calbiochem), anti-lamin A/C (Santa Cruz), and
anti-rpL5 antibodies (12), respectively. Similarly, total RNA was isolated from
the fractions obtained above and separated on formaldehyde-agarose gels. Sep-
arated RNA from each nuclear and cytoplasmic fraction was analyzed by Northern
blotting using a probe specific for the 5S rRNA. The 5S rRNA probe was obtained
by PCR using HeLa cell genomic DNA as the template and the following primers:
sense, 5-CCTTCAGCGTCTACGGCCATACC-3; antisense, 5-GCCAAGAAA
AAGCCTACAGCAGG-3. The PCR product was cloned and confirmed by se-
quencing.
RNA FISH. HeLa cells were subjected to the Nucleofector process with
pcDNA3.1 His, His-tagged NPM, or His-NPMdL and plated on coverslips. Cells
were subjected to RNA fluorescence in situ hybridization (FISH) as described
previously (3) using a tetramethyl rhodamine isocyanate (TRITC)-labeled 5S
rRNA probe (Genedetect). DNA was counterstained with DAPI (4,6-diami-
dino-2-phenylindole).
Ribosome fractionation. Cells were subjected to cytosolic and nuclear ribo-
some fractionation, and lysates were separated on sucrose gradients as previously
described (48). RNA was continuously monitored over the gradient by measuring
UV absorbance at 254 nm. Fractions were collected, and proteins were precip-
itated with TCA. Proteins were separated by SDS-PAGE and immunoblotted
with antibodies recognizing NPM (Zymed) and rpL5.
RESULTS
NPM nuclear export requires a CRM1-dependent nuclear
export signal involving leucines 42 and 44. NPM is a ubiqui-
tously expressed nucleolar phosphoprotein capable of regu-
lated nuclear import (6). When NPM is transiently expressed
in mammalian cells, it localizes predominantly to the nucleo-
lus. Moreover, using in vivo heterokaryon shuttling assays (50),
we have previously shown that NPM readily shuttles between
the nucleolus/nucleus and cytoplasm (7). NPC-M9, a nuclear
hnRNP protein that readily mobilizes to the cytoplasm, serves
as a shuttling control (40). To distinguish between human
donor and murine acceptor nuclei, chromosomal DNA was
stained with Hoechst, clearly demarcating greater heterochro-
matin foci of NIH 3T3 mouse cells (speckled pattern, Fig. 1,
Hoechst). As shown in Fig. 1A, NPM readily shuttles out of the
human nucleolus, into the fused cytoplasm, and back into the
mouse acceptor nucleus/nucleolus.
Given that a wide range of shuttling proteins utilize the
CRM1 transport protein for their nuclear export, we further
investigated the underlying export mechanism of NPM both in
the presence and absence of leptomycin B (LMB), a potent
inhibitor of CRM1-mediated nuclear export (24). In the ab-
sence of LMB, NPM readily migrated from human nucleoli to
mouse nucleoli (Fig. 1A). However, in the presence of LMB,
NPM failed to shuttle and was restricted to human nucleoli
within heterokaryons (92% inhibition; Fig. 1B). The addition
of LMB did not hinder the nucleocytoplasmic trafficking of
Myc-NPC-M9, an hnRNP that readily shuttles in a CRM1-
independent nuclear export pathway (38).
A sequence alignment of NPM residues with known CRM1-
dependent shuttling proteins revealed two motifs containing
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short leucine-rich hydrophobic stretches of amino acids char-
acteristic of CRM1-dependent nuclear export sequences
(NESs) (Fig. 1C) (14, 15). In order to identify which region(s)
of NPM contains its NES, we generated deletion mutants of
NPM lacking either of the two potential NESs (NPM42–61 and
NPM62–83). Using these NPM constructs, we again conducted
interspecies heterokaryon assays. As shown in Fig. 2A, deletion
of amino acids 42 to 61 of NPM (His-NPM42–61) prevented its
shuttling (100% inhibition) to mouse nucleoli. Importantly, a
myc-tagged NPC-M9 shuttling control readily shuttled in the
same human-mouse heterokaryon, indicating that these het-
erokaryons were not impaired for nucleocytoplasmic shuttling
in general. In contrast, deletion of amino acids 62 to 83 of
NPM (His-NPM62–83) did not prevent NPM from shuttling
between human and mouse nucleoli (6% inhibition; Fig. 2B),
revealing that the putative NES resides within amino acids 42
to 61 of the NPM protein.
Since the type of NES recognized and bound by the CRM1
export receptor is dependent on closely spaced hydrophobic
amino acids (particularly leucines) (14, 15), we introduced
point mutations into the corresponding leucine residues within
the NES of NPM (Leu-42 and Leu-44 to Ala-42 and Ala-44).
First, we tested this NPM mutant (designated NPMdL for
double-leucine mutant) with Myc-NPC-M9 as a shuttling con-
trol. As expected, NPMdL was unable to transit from a human
nucleus to the cytoplasm and into a murine nucleus (100%
FIG. 1. Nuclear export of NPM is CRM1 dependent. NIH 3T3 cells were seeded onto HeLa cells that had been transfected with His-NPM in
combination with Myc-NPC-M9 (shuttling control) in the (A) absence or (B) presence of LMB. Heterokaryons were incubated in media containing
cycloheximide for an additional 4 h before fixation. Heterokaryon formation was verified by phase-contrast microscopy, while His-NPM and
Myc-NPC-M9 proteins were visualized with antibodies against His (red) and Myc (green), respectively. DNA was stained with Hoechst. Mouse
nuclei are demarcated with dotted circles. Human and mouse nuclei are labeled h and m, respectively. These data are representative of at least
five independent heterokaryons formed for each transfection condition in three independent experiments. The percentages of His-NPM shuttling
in heterokaryons are given. DIC, differential interference contrast; , anti. (C) Sequence alignment of putative NPM NESs with known NESs of
CRM1-dependent nuclear export proteins (p53, protein kinase inhibitor [PKI], rev, and Mdm2). Critical hydrophobic residues are indicated in
yellow.
3800 YU ET AL. MOL. CELL. BIOL.
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FIG. 2. Leucine 42 and leucine 44 are identified as critical nuclear export residues. NIH 3T3 cells were seeded onto HeLa cells that had been
transfected with (A) His-NPM42–61, (B) His-NPM62–83, or (C) NPMdL in combination with Myc-NPC-M9. Ectopic NPM proteins and
Myc-NPC-M9 proteins were visualized with antibodies against His (red) and Myc (green), respectively. DNA was stained with Hoechst. Mouse
nuclei are demarcated with dotted circles. Human and mouse nuclei are labeled h and m, respectively. These data are representative of at least
five independent heterokaryons formed for each transfection condition in three independent experiments. The percentages of His-NPM shuttling
in heterokaryons are given. DIC, differential interference contrast; , anti. (D) Sequence alignment of NPM homologues throughout evolution.
Identical residues in all species are marked yellow, identical residues in at least seven species are highlighted blue, and conserved residues are
marked green. Crystal structure features are identified above the sequences. The consensus NPM sequence for all 11 identified homologues is
given, with conserved nuclear export leucines 42 and 44 marked with arrows (NES).
VOL. 26, 2006 NPM SHUTTLES rpL5 TO THE CYTOSOL 3801
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inhibition), indicating that these two leucine residues are crit-
ical for nuclear export of the NPM protein (Fig. 2C). Sequence
alignment of numerous nucleophosmin homologues under-
scores the evolutionary importance of this amino-terminal ex-
port motif as it is nearly identical from zebra fish to humans
(Fig. 2D).
Heterogeneous complexes containing NPM NES mutants
and wild-type NPM fail to shuttle. Because NPM readily self-
oligomerizes (32, 33, 34, 53), we considered the possibility that
mutant NPM molecules could form hetero-oligomers with
wild-type NPM proteins. To test this hypothesis, HeLa cells
were transduced with His-tagged NPMdL expression vectors.
Immunoprecipitation of His-NPMdL proteins revealed the co-
precipitation of wild-type endogenous NPM proteins, demon-
strating the formation of mutant–wild-type hetero-oligomers in
cells (Fig. 3A, right). Additionally, cells transduced with His-
NPMdL and GFP-NPM displayed formation of hetero-oligo-
mers, as observed by coprecipitation of both proteins using
antibodies directed at either epitope tag (His or GFP; Fig. 3A,
left). Given our finding that mutant NPM forms oligomers with
wild-type NPM, we next examined whether the NPM shuttling
mutant NPMdL could also block wild-type NPM from shut-
tling. In the absence of the shuttling mutant, GFP-tagged NPM
readily shuttled from human to mouse nucleoli (Fig. 3C). How-
ever, in the presence of His-tagged NPMdL, GFP-NPM was
retained in human nuclei (Fig. 3D; 96% inhibition). Although
we were unable to determine the exact stoichiometry between
mutant proteins and wild-type proteins in the NPM oligomer,
it is clear that overexpression of NPMdL severely impaired the
shuttling activity of nearly all NPM oligomers.
NPM associates with cytoplasmic and nuclear rpL5 ribo-
some complexes. Previous studies have indicated that NPM
might function as an integral component of ribosome matura-
tion through its RNA binding activities (36). However, most
hypotheses in this regard are largely based on the fact that
NPM is nucleolar and, thus, most likely to be involved in the
major process in the nucleolus: ribosome biogenesis. To for-
mally test the nucleolar function of NPM, we examined the
composition of in vivo NPM protein complexes in HeLa cell
lysates. We generated a custom NPM polyclonal antibody af-
finity column and used a control nonimmune immunoglobulin
column to preclear protein lysates. NPM complexes were
eluted with increasing salt concentrations and visualized
following SDS-PAGE and SYPRO-Ruby staining. As seen
in Fig. 4A, we observed very little protein bound to our non-
FIG. 3. NPM shuttling mutants act as dominant negative inhibitors
of NPM nuclear export. (A, left) HeLa cells transduced with His-
NPMdL and GFP-NPM were lysed, and the whole-cell lysate was
subjected to immunoprecipitation (IP) with NRS or antibodies recog-
nizing His and GFP epitopes. Precipitated protein complexes were
separated by SDS-PAGE, and ectopic NPM proteins were visualized
with antibodies against GFP and His epitopes. (A, right) HeLa cells
transfected with His-NPMdL were lysed, and the whole-cell lysate was
subjected to immunoprecipitation with NRS or antibodies recognizing
His epitopes. Precipitated protein complexes were separated by SDS-
PAGE, and ectopic mutant and endogenous wild-type NPM proteins
were visualized with antibodies against NPM. Untransfected HeLa
whole-cell lysate was loaded as a marker for endogenous NPM expres-
sion (lane 1). IB, immunoblot; , anti; DIC, differential interference
contrast. NIH 3T3 cells were seeded onto HeLa cells that had been
transfected with GFP-NPM (B) alone or (C) in combination with
His-NPMdL. Heterokaryon assays were performed, and His-NPMdL
and GFP-NPM proteins were visualized with antibodies against His
(red) or naturally emitting GFP spectra (green). DNA was stained with
Hoechst. Mouse nuclei are demarcated with dotted circles. Human
and mouse nuclei are labeled h and m, respectively. These data are
representative of at least five independent heterokaryons formed for
each transfection condition in three independent experiments. The
percentages of GFP-NPM shuttling in heterokaryons are given.
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immune rabbit serum column (lane 1). However, some pro-
teins (	18) were specifically eluted from the NPM antibody
column (lane 3), including NPM and the previously known
binding protein nucleolin. To determine whether the eluted
proteins were in fact bound to the column through their inter-
action with NPM, we depleted NPM from HeLa cells using
NPM-targeted RNA interference. Knockdown of NPM re-
sulted in a loss of specific proteins bound and eluted from the
NPM antibody column, demonstrating that our identified
NPM protein complex is specific for NPM (lane 2). Protein
bands were excised and identified using MALDI-TOF and
tandem mass spectrometry analyses. Among those proteins
bound to NPM, a cluster of proteins associated with ribosome
biogenesis, including rpL5 and nucleolin, as well as the nuclear
pore complex proteins Nup50 and Nup62, were identified (Fig.
4A and B), with nucleolin (C23) being the only known NPM
binding protein (26, 27). Western blot analysis of NPM protein
complexes verified the presence of these proteins in salt-eluted
fractions (data not shown).
Given the novelty and potentially significant ribosome biol-
ogy of finding rpL5 in the NPM complex, we focused on ver-
ifying the NPM-rpL5 interaction. Purified recombinant NPM,
NPMdL, and rpL5 proteins (Fig. 5A, left panels) mixed over-
night were coprecipitated (Fig. 5A, middle panels), demon-
strating that the NPM-rpL5 interaction is direct and indepen-
dent of the NPM nuclear export signal. To show that the
interaction of recombinant proteins was specific, NPM and
rpL5 were mixed overnight with recombinant p27kip1 proteins
(equally charged proteins not bound to the NPM antibody
column). Precipitated proteins exhibited no complex formation
between NPM and p27kip1 or rpL5 and p27kip1 (Fig. 5A, right
panels). Both NPM and rpL5 readily interact with RNAs
through conserved nucleic acid binding domains. To determine
whether RNA binding is required for the NPM-rpL5 interac-
tion, HeLa lysates were subjected to RNase A treatment prior
to coprecipitation of NPM-rpL5 complexes. Even in the pres-
ence of RNase A, NPM and rpL5 visibly formed in vivo protein
complexes (Fig. 5B) indistinguishable from those from un-
treated cells and consistent with our earlier finding that the
interaction can be recapitulated with purified recombinant
proteins (Fig. 5A). While NPM and rpL5 formed complexes in
vivo, serial immunoprecipitation of NPM proteins from HeLa
lysates showed that NPM and rpL5 are not exclusive partners.
We failed to detect rpL5 in some NPM complexes (Fig. 5C, 3o
and 4o), and we also noted that there was a significant amount
of rpL5 free from NPM complexes in the remaining superna-
tant (Fig. 5C, Sup), indicating that both NPM and rpL5 can
exist in complexes independent of one another.
Having identified a critical member of the 60S ribosomal
subunit, namely, rpL5, in NPM complexes, we wanted to eval-
uate the colocalization of NPM with ribosomes in vivo. In
order to follow the spatial control of NPM-rpL5 complexes in
vivo, we utilized the UV absorbance of the ribosome. Ribo-
somal protein L5 is known to supply the maturing 60S ribo-
somal subunit with 5S rRNA prior to nucleolar/nuclear export
of the 60S subunit (47), providing NPM an ideal time to form
nucleolar complexes with rpL5. Cytoplasmic and nuclear ex-
tracts of HeLa cells were subjected to sucrose gradient centrif-
ugation, and the gradients were fractionated with continuous
UV monitoring. As shown in Fig. 6, NPM associates with the
40S, 60S, 80S, and polysome fractions in the cytoplasm while
nuclear pools of NPM associate with the 40S/pre-60S and 60S
fractions in the nucleus. Consistent with previous reports (30),
we found rpL5 associated with the 60S, 80S, and polysome
fractions in the cytoplasm and the 40S/pre-60S and 60S frac-
tions in the nucleus (Fig. 6). These data demonstrate that NPM
and rpL5 are localized with the maturing 60S ribosomal sub-
units in the nucleus and are maintained in the mature ribo-
FIG. 4. Isolation of endogenous NPM protein complexes. (A) HeLa
cell lysates (600 g) transduced with control (
) or NPM-directed
RNA interference (RNAi) constructs () were injected onto either an
NRS column or custom NPM polyclonal antibody affinity columns and
eluted with an increasing NaCl gradient (0.1 to 1.0 M). Eluted proteins
were separated by SDS-PAGE and visualized with Coomassie blue
stain. Identified bands are labeled. (B) Representative MALDI-TOF
spectra of labeled protein bands from panel A are shown with labeled
matching peptide masses.
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some once it reaches the cytosol. They also indicate that NPM
also associates with the 40S subunit, which is devoid of rpL5
(Fig. 6) (30).
Transduction of HeLa cells with His-NPMdL resulted in a
dramatic redistribution of rpL5 in cytosolic ribosomes; rpL5
was maintained in the 60S subunits but severely reduced in 80S
ribosomes (Fig. 6, middle left panels). Given these findings, we
cannot rule out the possibility that rpL5 proteins are still ca-
pable of some NPM-independent shuttling. However, it is
more likely that rpL5 association with cytosolic ribosomes in
the presence of NPMdL is a result of preexisting, stable cyto-
solic rpL5 complexes. This notion is further substantiated by
treatment of HeLa cells with LMB. LMB treatment yielded
results that were consistent with NPMdL overexpression (Fig.
6, lower panel). Both NPM and rpL5 proteins were found in
the cytosol of LMB-treated cells (at reduced levels), even
though the nuclear export of both proteins is LMB sensitive. This
finding suggests that some preexisting cytosolic NPM and rpL5
ribosome complexes are fairly stable (	24 h) and that, if either
protein utilizes CRM1-independent export, it is minimal.
NPM is required for rpL5 nuclear export. Having demon-
strated a reduction of rpL5 associated with cytosolic ribosome
subunits in the absence of NPM nuclear export signals, we next
FIG. 5. NPM interacts directly with rpL5. (A, left) Recombinant NPM, NPMdL, and rpL5 were purified from bacterial lysates using
Ni-nitrilotriacetic acid affinity chromatography. Purified proteins were separated by SDS-PAGE and detected with Coomassie blue stain. (A,
middle) Purified NPM or NPMdL proteins were incubated overnight with rpL5 and immunoprecipitated (IP) with NRS or antibodies recognizing
NPM or rpL5. Precipitated proteins were separated by SDS-PAGE, transferred to PVDF membranes, and immunoblotted with NPM and rpL5
antibodies. (A, left) Purified NPM or rpL5 proteins were incubated overnight with recombinant p27 and immunoprecipitated with NRS or
antibodies recognizing NPM, rpL5, or p27. Precipitated proteins were separated by SDS-PAGE, transferred to PVDF membranes, and immu-
noblotted with NPM, rpL5, and p27 antibodies. , anti. (B) Proteins from HeLa cell lysates were immunoprecipitated with NRS, rpL5 antibody,
or NPM antibodies. Precipitated proteins were separated by SDS-PAGE, transferred to PVDF membranes, and immunoblotted with NPM and
rpL5 antibodies. Alternatively, HeLa lysates were pretreated for 1 h with RNase A prior to immunoprecipitation as described above. (C) HeLa
lysates were subjected to serial immunoprecipitation with NPM antibodies (lanes 1o to 4o). Precipitated proteins and proteins in the final
supernatant (unbound) were separated by SDS-PAGE, transferred to PVDF membranes, and immunoblotted with antibodies recognizing NPM
and rpL5.
FIG. 6. NPM and rpL5 colocalize with nuclear and cytosolic ribo-
some subunits. HeLa cells transduced with vector (top panels) or
His-NPMdL (middle panels) or treated with LMB (bottom panels)
were divided into cytoplasmic and nuclear fractions and subjected to
sucrose gradient centrifugation. Absorbance was monitored at 254 nm,
and fractions containing 40S, 60S, 80S, and polysome units were col-
lected. Proteins from each fraction were separated by SDS-PAGE,
transferred to PVDF membranes, and immunoblotted with antibodies
recognizing NPM, the His epitope, and rpL5. , anti.
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FIG. 7. NPM nuclear export signals are required for the efficient export of GFP-rpL5. (A) HeLa cells either untransfected or transfected with
GFP-tagged L5 for 48 h were harvested and lysed. Proteins were immunoprecipitated (IP) with NRS or a rabbit GFP antibody. Precipitated
proteins were separated by SDS-PAGE, transferred to PVDF membranes, and immunoblotted with GFP and NPM antibodies. , anti; DIC,
differential interference contrast. Loading inputs are indicated. (B to E) NIH 3T3 cells were seeded onto HeLa cells that had been transfected with
GFP-rpL5 in combination with (B and C) His-NPM, (D) His-NPM42–61, and (E) His-NPMdL. Additionally, HeLa cells in panel C were treated
with LMB for 18 h prior to fusion. Heterokaryon assays were performed with NPM and GFP-rpL5 proteins being visualized with antibodies against
His (red) and naturally emitting GFP spectra (green), respectively. DNA was stained with Hoechst. Mouse nuclei are demarcated with dotted
circles. Human and mouse nuclei are labeled h and m, respectively. These data are representative of at least five independent heterokaryons
formed in three independent experiments. The percentages of heterokaryons exhibiting GFP-rpL5 shuttling are given.
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FIG. 8. NPM is essential for rpL5 nuclear export. (A) HeLa cells (
) or cells transduced with siRNAs encoding either scrambled control or
NPM-specific sequences were harvested 72 h posttransduction for Western blot analysis. Proteins separated by SDS-PAGE were transferred to
PVDF membranes and immunoblotted with antibodies recognizing NPM and -tubulin. , anti. (B) HeLa cells (
) or cells transduced with
siRNAs encoding either scrambled control or NPM-specific sequences were harvested 72 h posttransduction for cellular fractionation. Proteins
from nuclear (N) and cytosolic (C) fractions were analyzed by SDS-PAGE and immunoblotted with antibodies recognizing rpL5, SOD (cytoplasm
control), and lamin A/C (nuclear control). (C) HeLa cells were transfected with His-NPM or His-NPMdL, and 24 h later equal numbers of cells
were subjected to fractionation into cytoplasmic (C) and nuclear (N) extracts. L5 protein was detected by Western blot analysis (top panels; WB).
Lamin A/C and SOD are shown as nuclear and cytoplasmic fractionation controls, respectively (top panels; WB). 5S rRNA was detected by
Northern blot analysis of total RNA extracted from the nuclear and cytosolic fractions (bottom panel; NB). The ratios of nuclear to cytoplasmic
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examined the direct influence of NPM shuttling mutants on
rpL5 nuclear export using a previously characterized GFP-
tagged rpL5 protein (41). To confirm that GFP-rpL5 retained
the NPM-binding properties of the endogenous rpL5 protein,
we transiently overexpressed GFP-rpL5 in HeLa cells and per-
formed Western blot analysis of GFP-immunoprecipitated
complexes. As shown in Fig. 7A, precipitated GFP-rpL5 com-
plexes contained endogenous NPM, confirming that the GFP
moiety does not adversely affect the formation of NPM-rpL5
complexes in vivo. GFP-rpL5 and His-NPM readily migrated
from human nucleoli to mouse nucleoli, as visualized in inter-
species heterokaryons (Fig. 7B). However, in the presence of
LMB, both GFP-rpL5 and His-NPM failed to shuttle (95%
inhibition; Fig. 7C). Introduction of NPM shuttling mutant
NPM42–61 or NPMdL inhibited GFP-rpL5 shuttling into
mouse nucleoli, restricting its expression to human nuclei (Fig.
7D and E; 96% and 100% inhibition, respectively), establishing
that NPM nuclear export is required for the export of rpL5. To
more definitively show that NPM is required for rpL5 nuclear
export, we knocked down NPM expression in HeLa cells (Fig.
8A). Cells lacking NPM protein expression failed to accumu-
late rpL5 in the cytoplasm, while cells transduced with scram-
bled small interfering RNA (siRNA) as a control exhibited an
equal distribution of rpL5 between the nucleus and cytoplasm
(Fig. 8B). These data underscore the necessity of NPM pro-
teins for the efficient transport of rpL5 out of the nucleus and
into the cytoplasm.
Ribosomal protein L5 is known to bind specifically to the
mature 5S rRNA and aid in its nucleocytoplasmic transport
(31, 37, 47). We hypothesized that NPM export, through its
influence on rpL5, is the critical determinant for 5S rRNA
nuclear export. To test this hypothesis, we performed Northern
blot analysis of similar cellular fractions in the presence and
absence of NPM shuttling. Indeed, in the presence of domi-
nant negative NPM shuttling mutants, 5S rRNA failed to ac-
cumulate in the cytosol and instead was retained in the nucleus
in a ratio similar to that for rpL5 (Fig. 8C). In addition to our
fractionation studies, we performed RNA FISH to visualize
the localization of steady-state levels of 5S rRNA. As shown in
Fig. 8D, 5S rRNA was distributed throughout the nucleoli/
nuclei and cytoplasm of HeLa cells transduced with empty
vector as well as with wild-type NPM. Consistent with our
fractionation data, inhibition of NPM and rpL5 nuclear export
with LMB or NPMdL resulted in a severe attenuation of 5S
rRNA export to the cytosol (Fig. 8D).
To further expand on this theme, we transduced wild-type
MEFs with ARF, a known inhibitor of NPM nuclear export
(7). Again, in the presence of the ARF tumor suppressor, 5S
rRNA failed to transit to the cytosol and instead was retained
the nucleoplasm (Fig. 8E). These data imply that ARF and
NPM mutants defective in shuttling act similarly to prevent
rpL5-5S rRNA nuclear export. To determine whether NPM
shuttling mutants also prevent cell cycle progression, HeLa
cells transduced with NPM expression constructs were labeled
with 5-bromodeoxyuridine (BrdU) to measure active DNA
synthesis. Similar to ARF’s known cell cycle arrest properties
(7), cells expressing NPMdL or NPM42–61 failed to enter S
phase (Fig. 8F). Thus, NPM shuttling activity is not only re-
quired for the nuclear export of the rpL5-5S rRNA complex
but also necessary for continued cell proliferation.
DISCUSSION
The nucleolus, a highly specialized and structured organelle,
has been described as the cell’s control center for ribosomal
synthesis, maturation, and assembly, with a host of proteins,
RNAs, and other factors being implicated in these processes (8).
Recently, numerous proteins (cdc14, NPM, cyclin E, Mybbp1a,
telomerase reverse transcriptase, and others) have been shown
to continuously shuttle from the nucleolus to various subcel-
lular compartments in a regulated manner, providing evidence
that the nucleolus is a dynamic site of multiple cellular events
(4, 7, 21, 22, 52).
One such protein, NPM/B23, has been linked to a variety of
important cellular processes, both in and out of the nucleolus,
including ribosome processing, molecular chaperoning, main-
tenance of genomic integrity, centrosome duplication, and
transcriptional regulation (9, 10, 13, 16, 23, 35). Initially, NPM
which was imported into the nucleolus from the cytoplasm was
presumed to move about the various compartments of the
nucleus (6), a feature shared by many critical cell cycle regu-
lators. This shuttling of proteins between the nucleus and cy-
toplasm is now recognized as a key mechanism for ensuring
proper cell cycle progression (39, 43). In previous reports, we
and others identified NPM as a novel p53-independent target
of the ARF tumor suppressor protein (5, 7, 19). We have since
shown that, in response to hyperproliferative signals, nucleolar
ARF directly binds NPM, effectively inhibiting NPM’s nucleo-
cytoplasmic shuttling. Here, we have further explored the
mechanism and significance of NPM intracellular trafficking.
First, we have described the CRM1-dependent nuclear export
of NPM, identifying the two leucine residues (42 and 44) that
are critical to this process. In addition, we have shown that
alteration of the NPM NES resulted in the failure of wild-type
NPM to be exported out of the nucleolus, providing evidence
that these mutations function in a dominant-negative fashion,
accumulation of rpL5 and 5S rRNA are given as percentages of totals (, P  0.001). (D) HeLa cells were transfected with vector, His-NPM, or
His-NPMdL, and cells were plated on glass coverslips. Twenty-four hours later, cells were subjected to RNA FISH with a TRITC-labeled 5S rRNA
probe. Nuclei were stained with DAPI. Untransfected HeLa cells were treated with LMB for 18 h prior to RNA FISH analysis. Results of 5S rRNA
localization are each representative of three independent experiments. (E) Wild-type (WT) MEFs were infected with control retroviruses or those
encoding ARF, and 48 h later equal numbers of cells were subjected to fractionation into cytoplasmic (C) and nuclear (N) extracts. 5S rRNA was
detected by Northern blot analysis of total RNA extracted from the nuclear and cytosolic fractions (, P  0.005). (F) HeLa cells were transfected
with vector, His-NPM, His-NPMdL, or His-NPM42–61 and plated on glass coverslips. Cells were incubated with BrdU 72 h posttransfection and
fixed 20 h later. Fixed cells were stained with antibodies recognizing BrdU and His epitopes and visualized by immunofluorescence using
fluorescein isothiocyanate- and TRITC-labeled secondary antibodies, respectively. Cells (100) were counted for each condition in triplicate.
Standard deviations are reported as error bars (, P  0.005).
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through the formation of NPM-NPMdL heteromultimers.
Thus, NPMdL mimics the effects of ARF induction by directly
impeding the nucleocytoplasmic shuttling of NPM through
direct interaction, further demonstrating that NPM must exit
the nucleolus/nucleus to maintain and promote cell growth.
We have previously proposed that targets of nucleolar se-
questration might in fact “ride the ribosome” from the nucle-
olus to the cytoplasm to engage in growth-promoting events
(45). In agreement with this hypothesis, our findings reveal a
direct interaction between NPM and rpL5, providing the first
physical link between NPM and ribosomal subunits. Much of
the field’s focus has been on the putative role of rpL5 in
delivering 5S rRNA to the nucleolus, following the initial tran-
scription of 5S rRNA by RNA polymerase III in the nucleo-
plasm (31, 37, 47). However, it is also possible that rpL5 is a
critical player in the export of the large ribosomal subunit
(60S), containing 5S rRNA, from the nucleolus/nucleus to the
cytoplasm after its assembly. Clearly, the latter events would
render themselves sensitive to NPM regulation, given that
NPM provides the necessary export signals and chaperoning
capabilities (via rpL5) required to transport components of the
ribosome to the cytosol. Indeed, inhibition of NPM nuclear
export via deletion or mutation of its NES prevented the traf-
ficking of rpL5, an integral component of the 60S ribosomal
subunit. Moreover, reduction of NPM expression through
RNA interference completely abolished the cytosolic stores of
rpL5, underscoring the absolute requirement for NPM in rpL5
nuclear export. Thus, our initial hypothesis of “riding the ri-
bosome” should be revised to “taking the ribosome for a ride.”
While many components of the ribosome, including rpL5,
encode their own NESs, it is clear that a single NES forms a
relatively weak interaction with CRM1 (25), suggesting a re-
quirement for additional NESs in the efficient export of com-
plexes. Consequently, proteins like NPM and NMD3 may have
evolved to serve this purpose. Additionally, NPM and rpL5
were found, in reduced amounts, in cytosolic 40S and 60S
complexes, respectively, after LMB treatment, implying either
that these particular protein-ribosome complexes are fairly
stable or that minor fractions of NPM and rpL5 utilize CRM1-
independent modes of transport from the nucleus. Considering
that the predominant function of rpL5 is to bind and mobilize
5S rRNA molecules, it was not surprising that 5S transport was
also NPM sensitive, and thus NPM contributes to the efficient
nuclear export of rpL5-5S rRNA complexes. However, NPM
was present in 40S, 60S, 80S, and polysomes in the cytoplasm,
implying that NPM, free (within the 40S subunit) or bound to
rpL5, remains associated with the mature ribosome as it as-
sembles and forms actively translating polysomes in the cy-
tosol. Taken together, these findings open up the possibility
that NPM might transmit additional cues (beyond nuclear ex-
port) to cytosolic ribosomes during translation, consistent with
nucleolus’s proposed role in dictating translation rates (28).
While it has been appreciated for several decades that
changes in nucleolar structure are reliable markers of cellular
transformation, experiments that provide a direct link between
nucleolar dysfunction and tumorigenesis remain to be con-
ducted. In fact, the nucleolus has largely been dismissed as a
static organelle, having little to no impact on the overall well-
being of the cell. However, this “nucleolar stigma” recently has
been challenged with the discovery that tumor suppressors,
such as p53 and ARF, play a direct role in regulating nucleolar
processes (5, 7, 42, 49). Interestingly, rpL5 is also a binding
partner of Mdm2 and p53 (12, 17, 29), suggesting that rpL5
may provide an intriguing mechanistic link between ARF and
ARF-binding partners. Clearly, through its interaction with
NPM, ARF is capable of inhibiting nuclear export of rpL5-5S
rRNA complexes. Inhibition of NPM-directed rpL5-5S nuclear
export by ARF or NPM mutants defective in shuttling results
in cell cycle arrest, demonstrating the importance of rpL5-5S
export in maintaining cell proliferation. Moreover, NPM itself is
a unique player in both the p53 and ARF responses (10, 11),
providing us with a glimpse of how this network of protein inter-
actions may inevitably become sensitive to oncogenic and tumor-
suppressive signals in determining tumorigenic cell fates.
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